Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs
(Reuters) – Swiss pharmaceutical giant Novartis will pay Monte Rosa Therapeutics $150 million upfront payment for a globa..
Headlines
All Posts

(Reuters) – Swiss pharmaceutical giant Novartis will pay Monte Rosa Therapeutics $150 million upfront payment for a globa..
Headlines

By Abhirup Roy Tesla CEO Elon Musk stunned investors and analysts with plans to grow vehicle sales by 30% next year, buoyed by a new, ..
Headlines

By Shubham Batra (Reuters) – The UK’s benchmark FTSE 100 index rose on Monday, led by travel and leisure shares as Trainli..
Investing

By Alberto Chiumento and Paolo Laudani (Reuters) – The rise of online shopping has led to swathes of store closures, casting dou..
Business

By Gwladys Fouche OSLO (Reuters) – The world’s largest sovereign wealth fund is falling short on its own climate expectati..
Investing

By Marcela Ayres WASHINGTON (Reuters) -A group of funds backed by the world’s 20 largest economies aimed at financing cli..
Headlines

By Marta Maciag and Nathan Vifflin (Reuters) -Accor, Europe’s largest hotel group by portfolio, on Thursday raised the bo..
Headlines

By Abigail Summerville NEW YORK (Reuters) – Brazilian meatpacker JBS and Mexico’s Sigma Alimentos are among those c..
Headlines

By Paolo Laudani, Ankika Biswas and Johann M Cherian (Reuters) -European shares gave up early gains to close little changed on ..
Headlines

By Kannaki Deka and Nathan Gomes (Reuters) -Harley-Davidson cut its annual revenue forecast as sticky inflation and high borrow..
Headlines